LEADER 03794nam  2200601Ia 450 
001 9910437808403321
005 20200520144314.0
010   $a1-4419-7862-3
024 7 $a10.1007/978-1-4419-7862-2
035   $a(CKB)2560000000102935
035   $a(EBL)1694245
035   $a(OCoLC)843346109
035   $a(SSID)ssj0000897235
035   $a(PQKBManifestationID)11489361
035   $a(PQKBTitleCode)TC0000897235
035   $a(PQKBWorkID)10901479
035   $a(PQKB)11159808
035   $a(DE-He213)978-1-4419-7862-2
035   $a(MiAaPQ)EBC1694245
035   $a(PPN)170486753
035   $a(EXLCZ)992560000000102935
100   $a20130522d2013      uy         0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 00$aCharacterization of protein therapeutics using mass spectrometry /$fGuodong Chen, editor
205   $a1st ed. 2013.
210   $aNew York $cSpringer$dc2013
215   $a1 online resource (408 p.)
300   $aDescription based upon print version of record.
311   $a1-4899-7364-8 
311   $a1-4419-7861-5 
320   $aIncludes bibliographical references and index.
327   $aCharacterization of Protein Therapeutics by Mass Spectrometry: Recent Developments and Future Directions -- The Use of Mass Spectrometry to Characterize the Metabolism of Peptide Therapeutics -- Quantitative Analysis of Biologics Using Mass Spectrometry -- Maximizing Structural Information from Whole Protein Tandem Mass Spectrometry -- Disulfide Linkages of an Albumin Fusion Protein -- Detailed Structural Characterization of Monoclonal Antibodies -- Application of Protein Mass Spectrometry in Impurity and Degradant Characterization -- Mass Spectrometry Methods to Analyze Higher Order Structure of Protein Therapeutics by Chemical Footprinting -- Aglycosylations Alters Protein Conformation in Antibodies Engineered with Specific Effector Functions Using HDX-MS -- Characterizing Biotherapeutic Protein 3D Structures by Electrospray Ion-Mobility Mass Spectrometry -- Oxford University, Characterization of Assemblies of Proteins by Mass Spectrometry.  .
330   $aProtein therapeutics? high efficacy, safety, and ability to treat life-threatening diseases such as cancer, inflammation and genetic disorders have revolutionized modern medicine. In 2012, 200 companies competed in this $90 billion year industry.   In Characterization of Protein Therapeutics using Mass Spectrometry, expert contributors from academia and industry highlight current approaches and future trends. The book discusses mass spectrometry techniques as related to the analysis of protein therapeutics, structural identification strategies and quantitative approaches. The book also covers various studies involving characterization of process related protein drug impurities/degradants, metabolites, PTMs and  higher order structures of protein therapeutics.   General practitioners in pharmaceutical research, specialists in analytical sciences, and graduate students studying mass spectrometry and pharmaceutical sciences will find this book useful because of  the  step-by-step approaches and new strategies to solve challenging problems related to protein therapeutics research and development.
606   $aMass spectrometry
606   $aProteins$xTherapeutic use
615  0$aMass spectrometry.
615  0$aProteins$xTherapeutic use.
676   $a54
676   $a543.65
676   $a572.6
676   $a599935
701   $aChen$b Guodong$01602827
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910437808403321
996   $aCharacterization of protein therapeutics using mass spectrometry$94184355
997   $aUNINA